The tumor suppressor CYLD acts as a deubiquitinase for mTOR to constrain its activity
What this study shows
An RNAi screen identified the tumor suppressor CYLD as a deubiquitinase that binds mTOR and removes non-degradative K63-linked ubiquitin chains from several of its residues, restraining both mTORC1 and mTORC2. Cells lacking CYLD show hyperactive mTORC1/2, higher protein synthesis, larger cell size and resistance to serum-starvation-induced cell death. In C. elegans, knocking down cyld-1 fully abolishes the extended lifespan of low-TORC1-activity mutants, and skin biopsies from CYLD cutaneous syndrome patients show mTORC1 hyperactivation. Preprint, not peer-reviewed.
At a glance
| Evidence type | PP Preprint, not peer-reviewed This is a preprint, not yet peer-reviewed -- treat its findings as provisional until formal publication. Preprints carry their own marker because peer-review status is a different question from which system was studied. |
| Study type | Preprint |
| Model system | Human cell lines (RNAi screen, CYLD loss of function); C. elegans cyld-1 knockdown in low-TORC1 lifespan mutants; skin biopsies from CYLD cutaneous syndrome patients |
| Journal | bioRxiv |
| Year | 2025 |
| Peer reviewed | No |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1101/2025.09.01.673523 · PMID 40950055 · Free full text (PMC12424753) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | CYLD knockdown/loss of function; cyld-1 RNAi in C. elegans |
| Target | mTOR K63-linked ubiquitination; mTORC1 and mTORC2 activity |
| Model | Human cells; C. elegans; human skin biopsies |
| Effect | CYLD loss raised mTORC1/2 activity, protein synthesis and cell size; cyld-1 knockdown reversed lifespan extension of low-TORC1 worms |
In the Atlas
Related topics
More studies on this topic
- Lysosomal mTORC2/PHLPP1/Akt regulate chaperone-mediated autophagy (2015)
- mTOR substrate phosphorylation in growth control (2022)
- A dynamic network model of mTOR signaling reveals TSC-independent mTORC2 regulation (2012)
- A systems study reveals concurrent activation of AMPK and mTOR by amino acids (2016)
Thank you. Your answer was counted anonymously.